Interview with Dominique Demonte, Director, Biopark Charleroi Brussels South
Could you tell our readers who are not familiar with the Biopark with an introduction of the Biopark and its…
Biopark Charleroi Brussels South
Last updated: 13.02.2014
Address: Rue Adrienne Bolland 8,
B-6041 Gosselies,Belgium
Tel: +32 2 650 9869
Company description
Biopark is more than just a university campus; it also hosts cutting edge technology and industry, with a range of businesses currently operating on the Biopark. The companies are able to grow in an environment where relationships can be built and ideas exchanged with all of those involved in biotech innovation: ULB and UMONS lab facilities and fundamental research, support for new businesses from promotion and research units, hosting facilities, and training in new technologies. Most of the businesses on the Biopark are ULB spin-offs that have been supported by the special environment and structure found therein.
Products and services
Finding practical applications for our findings is part of the duty of a University to contribute to the economic development of their host regions. The transfer of technology from a lab to a business application, and the protection of intellectual property rights, are essential to this process. There are a variety of structures within the Biopark that work closely with the scientists to provide support throughout the innovation process.
Interviews
Related
Jacques Marbehant – Senior Vice President, Head of Global Manufacturing,…
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
Belgium / New ‘Corona Commissioner’ to Coordinate COVID-19 Response
The new Belgian government has moved to streamline its response to the COVID-19 crisis with the appointment of…
Jan de Backer – CEO, Fluidda
Fluidda is the world leader in the field of functional respiratory imaging which combines HRCT scans and…
Kristel de Bisschop – General Manager, Pierre Fabre Benelux
Pierre Fabre Benelux General Manager Kristel de Bisschop discusses the challenges and opportunities inherent in…
Kevin Houdenaert – General Manager, Recordati Benelux & Nordics
Kevin Houdenaert, general manager for Benelux and the Nordics at Italian rare disease, specialty and primary care…
The Long Read / Belgium: The Multifaceted
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical…
Pharma Faces / Sonja Willems, Janssen Benelux
Belgium is a vitally important country for Johnson & Johnson’s pharmaceutical arm, Janssen, globally. In…
In Profile / Stéphane De Wit, A Pioneer in HIV Research
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in…
Hospital Reform in Belgium / A Guarantee of Better Care?
Belgium’s healthcare system was ranked fourth in Europe in 2019, outperforming its peers across a number of…
Carl Laurent – Managing Director, Siemens Healthineers BeLux
Carl Laurent, managing director and CEO of Siemens Healthineers BeLux, sits down with PharmaBoardroom to explain…
Axel De Muyt – General Manager & VP, Novo Nordisk Belgium
Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the…
Cell & Gene Therapy Launches / Zolgensma® in Belgium: Lessons Learned
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy…
